{"id":"W4376274083","doi":"10.1016/j.xkme.2023.100667","title":"Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients","year":2023,"lang":"en","type":"article","venue":"Kidney Medicine","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"Akebia Therapeutics; Vifor Pharma; Astellas Pharma; Angion; Vertex Pharmaceuticals; ReCor Medical; Gilead Sciences; AstraZeneca; Amgen","keywords":"Darbepoetin alfa; Mace; Medicine; Hazard ratio; Internal medicine; Myocardial infarction; Randomized controlled trial; Clinical endpoint; Adverse effect; Anemia; Dialysis; Clinical trial; Kidney disease; Stroke (engine); Randomization; Surgery; Percutaneous coronary intervention; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00206566,0.0004051364,0.002619878,0.0007143067,0.00007198859,0.000004339078,0.0002256025,0.0001840651,0.0002145782],"category_scores_gemma":[0.003497729,0.0001928699,0.0005126675,0.002879994,0.0009375587,0.00004640295,0.00008879302,0.000380504,0.000006623216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001541108,"about_ca_system_score_gemma":0.0005071698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008484266,"about_ca_topic_score_gemma":0.000280772,"domain_scores_codex":[0.9947113,0.0007566793,0.00175672,0.0006188931,0.001751314,0.0004050672],"domain_scores_gemma":[0.9957988,0.001314902,0.00100338,0.0008375019,0.0006489847,0.0003964718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7316189,0.002041108,0.2578875,0.00008298063,0.004655418,0.00002965219,0.0006519472,0.00001697954,0.00001642036,0.000007615542,0.001289736,0.001701821],"study_design_scores_gemma":[0.7144191,0.008203842,0.2667839,0.00085161,0.00886067,0.000001007135,0.0003166207,0.0001478288,0.00008880977,0.000002612368,0.0001710902,0.0001528623],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911128,0.00002788438,0.00001246054,0.003705232,0.0003301625,0.00355332,0.0001165361,0.00003871865,0.001102902],"genre_scores_gemma":[0.9964688,0.000198304,0.0001682911,0.0003735153,0.0001108889,0.00011023,0.002052264,0.00004260863,0.0004751214],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01719973,"threshold_uncertainty_score":0.7865008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02230205734394311,"score_gpt":0.3097796599208878,"score_spread":0.2874776025769447,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}